ANDA 205687, held by Essential Isotopes. Ammonia N-13.
As of Nov 16, 2026, ANDA 205687 (Ammonia N 13), held by Essential Isotopes, was first approved by FDA on Dec 17, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ammonia N 133.75mCi-260mCi/ML ยท injectable;intravenous | Ammonia N-13 | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters